Drug Safety : ADR Category 1
Mitotane
Hypothyroidism, hypogonadism, hypercholesterolaemia and mineralocorticoid insufficiency: 4 case reports Release Date: 28 Jan 2026 Update Date: 28 Jan 2026
Price :
$20
*